Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Nelfb is crucial for forming skin fat tissue by regulating genes needed for fat cell development.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Nanofat injection is safe and effective for improving skin texture and patient satisfaction.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Fatp4 is crucial for healthy skin development and function.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Hepatitis C treatment may cause frontal fibrosing alopecia.

The document's conclusion cannot be provided because the content is not available.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Neurotrophin-4 increases calcium current in specific mouse neurons through the PI3K pathway.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.